EEU - pharmacokinetic equation??? [Power / Sample Size]

posted by mittyri – Russia, 2017-12-29 13:11  – Posting: # 18126
Views: 25,542

Hi Yura,

» So I understand: imagine the power analysis and draw a conclusion (at low power) that since bioequivalence is established, a posteriori power rating does not affect the findings of the study
Yep. Once again: to be lucky is not a crime :-D
and vice versa: if the post-hoc power is -> 100%, you're a hero even if the study was overpowered de facto (i.e. CI [0.98-1.03]).

» More interesting question: the pharmacokinetic equation and its analysis ... :confused:
Good question! Next question!
Seems like they are interested in PK model which is not permitted. No clue so far :-|

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
20,793 posts in 4,353 threads, 1,445 registered users;
online 8 (0 registered, 8 guests [including 5 identified bots]).
Forum time: 00:06 UTC (Europe/Vienna)

In God we trust;
all others must bring data.    W. Edwards Deming

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5